Pharma Inc agrees to cap margins on non-price control drugs at 30%

A consensus to this effect was reached at a meeting held on Friday between the drug pricing regulator, pharma lobby groups and industry associations, said people present at the meeting. The 30% cap on trade margins was preferred over other proposals such as imposing a flat 100% trade margin on all medicines, including those within price control.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news